'Dose 2' diaporamas de présentation

858 views • 77 slides

Closed Testing and the Partitioning Principle

Closed Testing and the Partitioning Principle. Jason C. Hsu The Ohio State University MCP 2002 August 2002 Bethesda, Maryland. Principles of Test-Construction. Union-Intersection Testing UIT S. N. Roy Intersection-Union Testing IUT Roger Berger (1982) Technometrics Closed testing

623 views • 34 slides

Medical requirements for FFAG as proton beam sources

FFAG 2007, April 12-17, 2007 Grenoble. Medical requirements for FFAG as proton beam sources. Jacques BALOSSO, MD, PhD Radiation oncologiste UJF / INSERM / ETOILE. Plan. Why to use protons in radiotherapy ? What kind of tumors are presently treated by protons ?

501 views • 32 slides

Sequential versus Simultaneous Optimal Experimental Design on Dose and Sample times

Sequential versus Simultaneous Optimal Experimental Design on Dose and Sample times. Joakim Nyberg. Mats O. Karlsson and Andrew Hooker. Background. Traditionally Optimal Design (OD) has been about optimizing the sampling schedule in experiments. But OD is dependent on ALL design parameters.

229 views • 17 slides

National Vaccine Advisory Committee November 29, 2005

National Vaccine Advisory Committee November 29, 2005. Update on NIH H5N1 Vaccine Trials Linda C. Lambert Chief, Respiratory Diseases Branch Division of Microbiology and Infectious Diseases NIAID/NIH/DHHS. H5 inactivated vaccine candidate. rg A/Vietnam/1203/04 (H5N1)

405 views • 15 slides

Novel Complex Ceramic Oxides for Polyphase Ceramic Waste-Forms

Materials Research Society Scientific Basis for Nuclear Waste Management Symposium 2017. Novel Complex Ceramic Oxides for Polyphase Ceramic Waste-Forms. Robert Aughterson Gregory R. Lumpkin, Katherine L. Smith, Julie M. Cairney. Synroc: the waste solution.

112 views • 11 slides

Neda Esmailzadeh On behalf of HIVNAT 152 study team

Prevalence of insulin resistance and metabolic syndrome among HIV-infected children receiving lopinavir/ritonavir (LPV/r)-based antiretroviral therapy. Neda Esmailzadeh On behalf of HIVNAT 152 study team. A 48-week study of a randomized trial comparing the efficacy of

170 views • 3 slides

Enrolled & Randomized (n=245 )

82 views • 1 slides